OpenEvidence, the ChatGPT for doctors, raises $200M at $6B valuation
✍️ Rebecca Bellan, Tage Kene-Okafor, Anthony Ha, Sarah Perez, Techcrunch Events, .Post-Authors-List__Authors --Font-Size Var, Align-Items Center Display Flex Gap Var, .Post-Authors-List__Authors .Post-Authors-List__Author-Thumbs Display Flex Flex-Shrink Margin Padding .Post-Authors-List__Authors .Post-Authors-List__Author-Thumbs Li List-Style None Margin-Left Margin-Top Important .Post-Authors-List__Authors .Post-Authors-List__Author-Thumbs Li First-Child Margin-Left .Post-Authors-List__Authors .Post-Authors-List__Author-Thumbs .Post-Authors-List__Author-Thumb Background-Color Var, Border Solid Var --Wp--Custom--Color--White, Border-Radius📅 October 20, 2025 12:00 AM🕐 Scraped: October 20, 2025
Summary: Trained on medical journals from JAMA and the New England Journal of Medicine, the platform helps users quickly get answers to existing medical knowledge to help treat patients. Verified medical professionals can access OpenEvidence’s tool, which is supported by advertising, for free.
In Brief
OpenEvidence, a tool that doctors and nurses have likened to ChatGPT for medicine, plans to announce a $200 million raise at a $6 billion valuation,
📰
Continue Reading on TechCrunch
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.